Generic Name and Formulations:
Bethanechol chloride 5mg, 10mg, 25mg, 50mg; scored tabs.
Indications for URECHOLINE:
Post-op and post-partum nonobstructive urinary retention and retentive neurogenic urinary atony.
Take on empty stomach. Initially 5–10mg every hour until effective or max 50mg, then 10–50mg 3–4 times daily.
Hyperthyroidism. Peptic ulcer. Asthma. Bradycardia. Hypotension. Vasomotor instability. Coronary artery disease. Epilepsy. Parkinsonism. Obstructive uropathies. Questionable GI or bladder integrity. Obstructive, spastic, inflammatory GI disorders. Vagotonia. Peritonitis. When increased GI or bladder muscle activity may be harmful.
Reflux urinary infection. Pregnancy (Cat.C). Nursing mothers: not recommended.
Severe abdominal symptoms and hypotension with ganglionic blockers.
Cholinergic effects, GI upset, asthma, headache, facial flushing, malaise, orthostatic hypotension.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- Can A Consortium of Hospitals Help To Reduce Drug Prices?
- NSCLC: Stratifying Patients With Complex EGFR Mutations
- Targeted and Immunotherapies for Metastatic Renal Cell Carcinoma
- Atezolizumab, Carboplatin, Nab-Paclitaxel Combination Prolongs PFS in NSCLC
- Everolimus Plus Letrozole: An Effective First-Line Therapy for Advanced Breast Cancer
- FDA Approves Nilotinib for Pediatric Patients With CML
- Nicotinamide and Cancer
- Nivolumab Plus Ipilimumab Improves Overall Survival, ORR in Renal Cell Carcinoma
- Encorafenib, Binimetinib May Be Effective in BRAF-Mutant Melanoma